Sequenom Posts 16 Percent Revenue Growth for Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its third-quarter revenues increased 16 percent year over year, with strong growth for its diagnostics services business.

The San Diego-based maker of molecular diagnostics and genetic analysis products had total revenues of $13.6 million for the three months ended Sept. 30, compared to $11.7 million for the third quarter of 2010. It fell short of analysts' consensus estimate of $13.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.